Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: URN022
MIFTS: 28

Urinary Tract Infections, Recurrent

Categories: Nephrological diseases
Genes Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Urinary Tract Infections, Recurrent

About this section

MalaCards integrated aliases for Urinary Tract Infections, Recurrent:

Name: Urinary Tract Infections, Recurrent 57
Urinary Tract Infections, Recurrent, Susceptibility to 57 29
Recurrent Urinary Tract Infections 29
Urinary Tract Infection Recurrent 55
Recurrent Urinary Tract Infection 73

Classifications:

MalaCards categories:
Anatomical: Nephrological diseases
See all MalaCards categories (disease lists)


External Ids:

OMIM 57 603806
UMLS 73 C0262655
Sources

Summaries for Urinary Tract Infections, Recurrent

About this section
MalaCards based summary : Urinary Tract Infections, Recurrent, also known as urinary tract infections, recurrent, susceptibility to, is related to acute cystitis and ectrodactyly and ectodermal dysplasia without cleft lip/palate. An important gene associated with Urinary Tract Infections, Recurrent is CXCR1 (C-X-C Motif Chemokine Receptor 1). The drugs Cranberry and Ofloxacin have been mentioned in the context of this disorder. Affiliated tissues include kidney, colon and spinal cord.

Description from OMIM: 603806
Sources

Related Diseases for Urinary Tract Infections, Recurrent

About this section

Diseases related to Urinary Tract Infections, Recurrent via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 48)
# Related Disease Score Top Affiliating Genes
1 acute cystitis 11.7
2 ectrodactyly and ectodermal dysplasia without cleft lip/palate 11.1
3 ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 1 11.1
4 hypomagnesemia 3, renal 11.1
5 actg2-related disorders 11.1
6 familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis 11.1
7 hereditary xanthinuria 11.1
8 vesicoureteral reflux 1 10.3
9 cystitis 10.3
10 bacteriuria 10.2
11 cystitis cystica 10.1
12 sexual disorder 10.1
13 interstitial cystitis 10.1
14 pelvic organ prolapse 10.0
15 pyuria 10.0
16 prostatic adenoma 10.0
17 urethral diverticulum 10.0
18 idiopathic hypercalciuria 10.0
19 hepatocellular carcinoma 9.8
20 carney complex, type 1 9.8
21 pheochromocytoma 9.8
22 cerebrotendinous xanthomatosis 9.8
23 mckusick-kaufman syndrome 9.8
24 prostatic hyperplasia, benign 9.8
25 polydactyly 9.8
26 caronte 9.8
27 leukemia, acute lymphoblastic 9.8
28 acute lymphocytic leukemia 9.8
29 bartter disease 9.8
30 leukemia 9.8
31 spinal cord injury 9.8
32 hemorrhagic cystitis 9.8
33 endocarditis 9.8
34 lymphocytic leukemia 9.8
35 hypospadias 9.8
36 bladder calculus 9.8
37 pyelonephritis 9.8
38 prostatitis 9.8
39 cystadenoma 9.8
40 adenocarcinoma 9.8
41 rhabdomyosarcoma 9.8
42 pleomorphic rhabdomyosarcoma 9.8
43 mood disorder 9.8
44 vaginal discharge 9.8
45 hypokalemia 9.8
46 diverticulitis 9.8
47 horseshoe kidney 9.8
48 antenatal bartter syndrome 9.8

Graphical network of the top 20 diseases related to Urinary Tract Infections, Recurrent:



Diseases related to Urinary Tract Infections, Recurrent
Sources

Symptoms & Phenotypes for Urinary Tract Infections, Recurrent

About this section

Clinical features from OMIM:

603806
Sources

Drugs & Therapeutics for Urinary Tract Infections, Recurrent

About this section

Drugs for Urinary Tract Infections, Recurrent (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 586)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Cranberry Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
2
Ofloxacin Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 82419-36-1 4583
3
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 100986-85-4 149096
4
Trimethoprim Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 738-70-5 5578
5
Nitrofurantoin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 67-20-9 5353830
6
Sulbactam Approved Phase 4,Phase 3,Phase 2 68373-14-8
7
Piperacillin Approved Phase 4,Phase 3,Phase 2,Not Applicable 66258-76-2 43672
8
Iodine Approved, Investigational Phase 4,Phase 2,Not Applicable 7553-56-2 807
9
Povidone Approved Phase 4,Phase 2,Not Applicable 9003-39-8
10
Povidone-iodine Approved Phase 4,Phase 2,Not Applicable 25655-41-8
11
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 1,Not Applicable 55-56-1 2713 9552079
12
acetic acid Approved Phase 4 64-19-7 176
13
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 2 9004-61-9 53477741
14
Cefotaxime Approved Phase 4,Not Applicable 63527-52-6 456256 5742673
15
Ciprofloxacin Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 85721-33-1 2764
16
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 26787-78-0 33613
17
Azithromycin Approved Phase 4,Not Applicable 83905-01-5 55185 447043
18
Vancomycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 1404-90-6 14969 441141
19
Cefoxitin Approved Phase 4,Not Applicable 35607-66-0 441199
20
Imipenem Approved Phase 4,Phase 3,Phase 2 74431-23-5, 64221-86-9 104838
21
Tamsulosin Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 106133-20-4 129211
22
Finasteride Approved Phase 4 98319-26-7 57363
23
Bethanechol Approved Phase 4 674-38-4 2370
24
Metronidazole Approved Phase 4,Phase 3,Not Applicable,Early Phase 1 443-48-1 4173
25
Tranexamic Acid Approved Phase 4,Phase 3,Not Applicable 1197-18-8 5526
26
leucovorin Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 58-05-9 6006 143
27
Methenamine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 100-97-0 4101
28
Sulfamethoxazole Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 723-46-6 5329
29
Fosfomycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 23155-02-4 446987
30
Acetylcholine Approved Phase 4,Phase 1,Phase 2,Early Phase 1,Not Applicable 51-84-3 187
31
Cephalexin Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 15686-71-2 27447
32
Cefuroxime Approved Phase 4,Not Applicable,Early Phase 1 55268-75-2 5361202 5479529
33
Ceftriaxone Approved Phase 4,Phase 3,Phase 2 73384-59-5 5479530 5361919
34
Ampicillin Approved, Vet_approved Phase 4,Not Applicable 69-53-4 6249
35
Cefazolin Approved Phase 4,Phase 1,Not Applicable 25953-19-9 656510 33255
36
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Not Applicable 302-25-0
37
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 83-43-2 6741
38
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Not Applicable 2921-57-5
39
Mycophenolic acid Approved Phase 4,Phase 2,Phase 1,Not Applicable 24280-93-1 446541
40
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 50-24-8 5755
41
Tacrolimus Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 104987-11-3 445643 439492
42
Racepinephrine Approved Phase 4,Phase 3,Not Applicable 329-65-7 838
43
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Not Applicable 51-43-4 5816
44
Tobramycin Approved, Investigational Phase 4 32986-56-4 36294 5496
45
Zinc Approved, Investigational Phase 4,Phase 3,Not Applicable 7440-66-6
46
Bacitracin Approved, Vet_approved Phase 4,Phase 1 1405-87-4 10909430 439542
47
Neomycin Approved, Vet_approved Phase 4,Early Phase 1 1404-04-2 8378
48
Cefixime Approved, Investigational Phase 4,Phase 3,Phase 2 79350-37-1 5362065 54362
49
Ibuprofen Approved Phase 4 15687-27-1 3672
50
Cilastatin Approved, Investigational Phase 4,Phase 3,Phase 2 82009-34-5 6435415 5280454

Interventional clinical trials:

(show top 50) (show all 1018)
# Name Status NCT ID Phase Drugs
1 Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women Unknown status NCT00900653 Phase 4 Gynoflor E (low dose estriol with lactobacillus)
2 Cranberry for the Prevention of Urinary Tract Infections Unknown status NCT02454309 Phase 4
3 The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females Unknown status NCT02094703 Phase 4 Levofloxacin;Solifenacin succinate;Placebo (for Solifenacin succinate)
4 Effects of Antibiotic Prophylaxis on Recurrent UTI in Children Unknown status NCT02357758 Phase 4 Antibiotic Prophylaxis
5 Gentamicin Bladder Instillation Trial Unknown status NCT01884467 Phase 4 Gentamicin;Placebo
6 Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a Previous Urinary Tract Infection Unknown status NCT00156546 Phase 4 antibiotic to reduce the recurrence of infection
7 Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection Unknown status NCT01897831 Phase 4 xin te mie
8 BIP Foley in Prevention of CAUTI at Rehab Station Unknown status NCT02808000 Phase 4
9 Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection Unknown status NCT01760109 Phase 4 Piperacillin Sodium and Sulbactam Sodium
10 Effect of Chlorhexidine on Bacteriuria Unknown status NCT02032394 Phase 4 Povidone-iodine;Chlorhexidine;Normal saline
11 Bladder Lavage as Decontamination Method for Asymptomatic Bacteriuria With Uropathogens in Catheterized Patients Unknown status NCT01772875 Phase 4
12 Clinical Impact of Bacteriuria on Chronic Inflammation in Asymptomatic Hemodialysis Patients Unknown status NCT01570556 Phase 4
13 A Prospective Study Comparing the Success Rate of Injection of (DefluxR) Versus (VantrisR) for VUR in Children Unknown status NCT02271035 Phase 4 Deflux;Vantris
14 Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis Unknown status NCT01820026 Phase 4 Imipenem;Vancomycin;azithromycin;Cefotaxime;Amoxicillin
15 Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients Unknown status NCT01736033 Phase 4 Tamsulosin;Finasteride;Placebo
16 Efficiency of Cold vs. Laser Internal Urethrotomy Treatment of Urethral Strictures Unknown status NCT01196572 Phase 4
17 Effectiveness of Bethanechol Chloride and Early Bladder Training for Prevention of Bladder Dysfunction After Radical Hysterectomy in Cervical Cancer Stage IB - IIA Unknown status NCT02910596 Phase 4 bethanechol chloride
18 Effect of Enteral Genistein Supplementation in Sepsis Unknown status NCT02796794 Phase 4
19 Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury Unknown status NCT00201968 Phase 4
20 Ciprofloxacin for Prevention of BK Infection Unknown status NCT01789203 Phase 4 Ciprofloxacin;placebo
21 Diverticulitis: Antibiotics or Close Observation? Unknown status NCT01111253 Phase 4 Amoxicillin-clavulanate
22 Tranexamic Acid in Knee Joint Surgery Unknown status NCT02278263 Phase 4 Tranexamic Acid;Normal saline (0.9% NaCl)
23 The Effect of Chest Tubes Using Active Clearance Technology® on the Incidence of Postoperative Atrial Fibrillation Unknown status NCT02808897 Phase 4
24 Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs Active, not recruiting NCT03077711 Phase 4 Trimethoprim;Methenamine hippurate
25 Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients Completed NCT03235947 Phase 4 Fosfomycin disodium;Trimethoprim / Sulfamethoxazole;Intravenous placebo
26 Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection Recruiting NCT03508921 Phase 4 Extended Antibiotics
27 Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection Recruiting NCT03099863 Phase 4 Cystoscopic Fluid containing Neosporin G. U. Irrigant;Cystoscopic Fluid/Placebo
28 Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI) Completed NCT01450800 Phase 4 Nitrofurantoin;Placebo
29 Clinical Study of Sanjin Tablets for the Treatment of Acute Simple Lower Urinary Tract Infection Not yet recruiting NCT03658291 Phase 4 Sanjin tablets;Sanjin tablets simulants;Levofloxacin
30 Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection Withdrawn NCT02034890 Phase 4 Hyaluronic Acid
31 Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections Completed NCT00318591 Phase 4
32 Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in Adults Completed NCT01092351 Phase 4 Nitrofurantoin
33 Cranberry on Urinary Tract Infections Withdrawn NCT01881165 Phase 4 Cranberry;Placebo
34 Febrile Urinary Tract Infection Randomized Short Treatment Trial Completed NCT00809913 Phase 4 short treatment (ciprofloxacin)
35 Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial Recruiting NCT03151603 Phase 4 Arctuvan;Fosfomycin;Placebo to Arctuvan;Placebo to Fosfomycin
36 Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder Completed NCT01388413 Phase 4 Weekly Oral Cyclic Antibiotic programme
37 Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery Recruiting NCT03287089 Phase 4 Nitrofurantoin 100 MG;Placebo Oral Tablet
38 Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens Completed NCT00481689 Phase 4 Cipro XR (Ciprofloxacin, BAYQ3939)
39 Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections Completed NCT00669994 Phase 4 Ciprofloxacin
40 Preventing Recurrent Urinary Tract Infections With α-D-mannose Recruiting NCT03497598 Phase 4 Mannose;Lactose
41 Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI) Completed NCT03366207 Phase 4 Ciprofloxacin
42 Efficacy of Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney Transplantation Completed NCT01820897 Phase 4 Fosfomycin-Trometamol;Sulfamethoxazole trimethoprim
43 Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women Active, not recruiting NCT01966653 Phase 4 nitrofurantoin;fosfomycin
44 Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - ICUTI Completed NCT01488955 Phase 4 Ibuprofen;Fosfomycin-Trometamol
45 INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTI Recruiting NCT03299387 Phase 4 Nitrofurantoin;Gentamicin
46 Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli Terminated NCT02474706 Phase 4 Cefoxitin;imipenem
47 Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae Active, not recruiting NCT02681263 Phase 4 Temocillin
48 Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of Time Terminated NCT00245791 Phase 4 Levofloxacin
49 Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women Completed NCT01958073 Phase 4 Conjugated Estrogen Vaginal Cream;Estradiol Ring;Placebo
50 Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae Withdrawn NCT01543347 Phase 4 Temocillin

Search NIH Clinical Center for Urinary Tract Infections, Recurrent

Sources

Genetic Tests for Urinary Tract Infections, Recurrent

About this section

Genetic tests related to Urinary Tract Infections, Recurrent:

# Genetic test Affiliating Genes
1 Urinary Tract Infections, Recurrent, Susceptibility to 29
2 Recurrent Urinary Tract Infections 29
Sources

Anatomical Context for Urinary Tract Infections, Recurrent

About this section

MalaCards organs/tissues related to Urinary Tract Infections, Recurrent:

41
Kidney, Colon, Spinal Cord, Prostate, T Cells, B Cells
Sources

Publications for Urinary Tract Infections, Recurrent

About this section

Articles related to Urinary Tract Infections, Recurrent:

(show all 40)
# Title Authors Year
1
Stigma and self-management: an Interpretative Phenomenological Analysis of the impact of chronic recurrent urinary tract infections after spinal cord injury. ( 29449969 )
2018
2
An exceptional source of recurrent urinary tract infections in women: Primary retroperitoneal serous cystadenoma. ( 29458894 )
2018
3
Incidental Finding of Urethral Diverticulum in a Woman with History of Recurrent Urinary Tract Infections. ( 29692697 )
2018
4
Role of increasing leukocyturia for detecting the transition from asymptomatic bacteriuria to symptomatic infection in women with recurrent urinary tract infections: A new tool for improving antibiotic stewardship. ( 30008180 )
2018
5
Editorial Comment to Role of increasing leukocyturia for detecting the transition from asymptomatic bacteriuria to symptomatic infection in women with recurrent urinary tract infections: A new tool for improving antibiotic stewardship. ( 30008187 )
2018
6
Native kidney pyelonephritis as the cause of recurrent urinary tract infections in a kidney transplant recipient. ( 29475548 )
2018
7
Recurrent urinary tract infections and low secretory IgA following CD19-directed CAR T-cell therapy for relapsed acute lymphoblastic leukemia. ( 28766894 )
2018
8
Endoscopic Treatment for Vesicoureteral Reflux in Recurrent Urinary Tract Infections in Kidney Transplant: Experience of One Center. ( 29579838 )
2018
9
Delayed diagnosis of primary vesicoureteral reflux in children with recurrent urinary tract infections: Diagnostic approach and renal outcomes. ( 29875036 )
2018
10
The effect of intravesical instillations with Hyaluronic Acid on sexual dysfunction in women with recurrent urinary tract infections (RUTI). ( 29277046 )
2018
11
Recurrent Urinary Tract Infections in a Female Child With Polydactyly and a Pelvic Mass: Consider the McKusick-Kaufman Syndrome. ( 28153592 )
2017
12
Urinary NGAL deficiency in recurrent urinary tract infections. ( 28210838 )
2017
13
Recurrent urinary tract infections in psychotic mood disorders. ( 27908584 )
2017
14
Re: Six out of Ten Women with Recurrent Urinary Tract Infections Complain of Distressful Sexual Dysfunction-A Case-Control Study. ( 28905762 )
2017
15
Six Out of Ten Women with Recurrent Urinary Tract Infections Complain of Distressful Sexual Dysfunction - A Case-Control Study. ( 28295051 )
2017
16
Recurrent Urinary Tract Infections in Children With Bladder and Bowel Dysfunction. ( 26647376 )
2016
17
Efficacy of Cranberry in Preventing Recurrent Urinary Tract Infections: Have We Learned Anything New? Commentary on: Effect of Cranberry Capsules on Bacteriuria Plus Pyuria Among Older Women in Nursing Homes: A Randomized Clinical Trial. ( 28024965 )
2016
18
Complete Genome Sequence of a CTX-M-15-Producing Escherichia coli Strain from the H30Rx Subclone of Sequence Type 131 from a Patient with Recurrent Urinary Tract Infections, Closely Related to a Lethal Urosepsis Isolate from the Patient's Sister. ( 27174264 )
2016
19
Supplementation with high titer cranberry extract (Anthocran®) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study. ( 28051247 )
2016
20
Mannose-binding lectin genetic analysis: possible protective role of the HYPA haplotype in the development of recurrent urinary tract infections in men. ( 24321858 )
2014
21
Ultrasound distinction between simple recurrent urinary tract infections and a specific bladder wall inflammatory entity called cystitis cystica. ( 24851610 )
2014
22
The predictive value of urinary UPIb mRNA levels in VUR and recurrent urinary tract infections. ( 24559587 )
2014
23
Efficient and cost-effective alternative treatment for recurrent urinary tract infections and interstitial cystitis in women: a two-case report. ( 25587284 )
2014
24
Urinary tract abnormalities in boys with recurrent urinary tract infections after hypospadias repair. ( 24053220 )
2014
25
Ultrasound bladder wall thickness measurement in diagnosis of recurrent urinary tract infections and cystitis cystica in prepubertal girls. ( 23725853 )
2013
26
The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? ( 22677710 )
2012
27
Recurrent Urinary Tract Infections due to Asymptomatic Colonic Diverticulitis. ( 22454651 )
2012
28
Asymptomatic proteinuria in a child with recurrent urinary tract infections--questions. ( 21993968 )
2012
29
The clinical effectiveness of intravesical sodium hyaluronate (cystistat®) in patients with interstitial cystitis/painful bladder syndrome and recurrent urinary tract infections. ( 24917721 )
2012
30
Bladder calculus presenting as recurrent urinary tract infections: a late complication of cervical cerclage placement: a case report. ( 21542538 )
2011
31
B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections. ( 22019034 )
2011
32
Complete duplication of collecting system in a horseshoe kidney presenting with recurrent urinary tract infections: report of an exceedingly rare congenital anomaly and review of literature. ( 22224073 )
2011
33
Pheochromocytoma presenting as recurrent urinary tract infections : a case report. ( 21226896 )
2011
34
Recurrent urinary tract infections in an infant with antenatal Bartter syndrome. ( 20127218 )
2011
35
Risk factors for recurrent urinary tract infections in a cohort of patients with primary vesicoureteral reflux. ( 20135833 )
2010
36
Cystitis cystica and recurrent urinary tract infections in children. ( 20977079 )
2010
37
Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? ( 17383810 )
2007
38
Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections. ( 16339057 )
2005
39
Recurrent urinary tract infections and genitourinary tract abnormalities in the Imerslund-GrAosbeck syndrome. ( 10845232 )
2000
40
[Recurrent urinary tract infections. Biological suppositions and clinical treatment with thymopentin]. ( 9557507 )
1997
Sources

Variations for Urinary Tract Infections, Recurrent

About this section
Sources

Expression for Urinary Tract Infections, Recurrent

About this section
Search GEO for disease gene expression data for Urinary Tract Infections, Recurrent.
Sources

Pathways for Urinary Tract Infections, Recurrent

About this section
Sources

GO Terms for Urinary Tract Infections, Recurrent

About this section
Sources

Sources for Urinary Tract Infections, Recurrent

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....